List of Tables
Table 1. Monoclonal Antibody Drug Market Trends
Table 2. Monoclonal Antibody Drug Market Drivers & Opportunity
Table 3. Monoclonal Antibody Drug Market Challenges
Table 4. Monoclonal Antibody Drug Market Restraints
Table 5. Global Monoclonal Antibody Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Monoclonal Antibody Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Monoclonal Antibody Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Monoclonal Antibody Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Monoclonal Antibody Drug
Table 10. Global Monoclonal Antibody Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Monoclonal Antibody Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Monoclonal Antibody Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Monoclonal Antibody Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Monoclonal Antibody Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Monoclonal Antibody Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Monoclonal Antibody Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Monoclonal Antibody Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Monoclonal Antibody Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Monoclonal Antibody Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Monoclonal Antibody Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Monoclonal Antibody Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Monoclonal Antibody Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Monoclonal Antibody Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Monoclonal Antibody Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Monoclonal Antibody Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Monoclonal Antibody Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Monoclonal Antibody Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Monoclonal Antibody Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Basic Information List
Table 32. Abbott Description and Business Overview
Table 33. Abbott Monoclonal Antibody Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Abbott (2019-2024)
Table 35. Abbott Recent Developments
Table 36. Johnson & Johnson Basic Information List
Table 37. Johnson & Johnson Description and Business Overview
Table 38. Johnson & Johnson Monoclonal Antibody Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Johnson & Johnson (2019-2024)
Table 40. Johnson & Johnson Recent Developments
Table 41. Roche Basic Information List
Table 42. Roche Description and Business Overview
Table 43. Roche Monoclonal Antibody Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Roche (2019-2024)
Table 45. Roche Recent Developments
Table 46. Ono Pharmaceutical Basic Information List
Table 47. Ono Pharmaceutical Description and Business Overview
Table 48. Ono Pharmaceutical Monoclonal Antibody Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Ono Pharmaceutical (2019-2024)
Table 50. Ono Pharmaceutical Recent Developments
Table 51. Amgen Basic Information List
Table 52. Amgen Description and Business Overview
Table 53. Amgen Monoclonal Antibody Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Amgen (2019-2024)
Table 55. Amgen Recent Developments
Table 56. Merck Basic Information List
Table 57. Merck Description and Business Overview
Table 58. Merck Monoclonal Antibody Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Merck (2019-2024)
Table 60. Merck Recent Developments
Table 61. Jiangsu Hengrui Pharmaceuticals Basic Information List
Table 62. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 63. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Jiangsu Hengrui Pharmaceuticals (2019-2024)
Table 65. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 66. Beigene Basic Information List
Table 67. Beigene Description and Business Overview
Table 68. Beigene Monoclonal Antibody Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Beigene (2019-2024)
Table 70. Beigene Recent Developments
Table 71. Shanghai Junshi Biosciences Basic Information List
Table 72. Shanghai Junshi Biosciences Description and Business Overview
Table 73. Shanghai Junshi Biosciences Monoclonal Antibody Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Shanghai Junshi Biosciences (2019-2024)
Table 75. Shanghai Junshi Biosciences Recent Developments
Table 76. Innovent Biologics Basic Information List
Table 77. Innovent Biologics Description and Business Overview
Table 78. Innovent Biologics Monoclonal Antibody Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Innovent Biologics (2019-2024)
Table 80. Innovent Biologics Recent Developments
Table 81. WuXi Biologics (Cayman) Basic Information List
Table 82. WuXi Biologics (Cayman) Description and Business Overview
Table 83. WuXi Biologics (Cayman) Monoclonal Antibody Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Monoclonal Antibody Drug Business of WuXi Biologics (Cayman) (2019-2024)
Table 85. WuXi Biologics (Cayman) Recent Developments
Table 86. Shanghai Henlius Biotech Basic Information List
Table 87. Shanghai Henlius Biotech Description and Business Overview
Table 88. Shanghai Henlius Biotech Monoclonal Antibody Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Shanghai Henlius Biotech (2019-2024)
Table 90. Shanghai Henlius Biotech Recent Developments
Table 91. Akeso Basic Information List
Table 92. Akeso Description and Business Overview
Table 93. Akeso Monoclonal Antibody Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Akeso (2019-2024)
Table 95. Akeso Recent Developments
Table 96. Lepu Biopharma Basic Information List
Table 97. Lepu Biopharma Description and Business Overview
Table 98. Lepu Biopharma Monoclonal Antibody Drug Products, Services and Solutions
Table 99. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Lepu Biopharma (2019-2024)
Table 100. Lepu Biopharma Recent Developments
Table 101. CStone Pharmaceuticals Basic Information List
Table 102. CStone Pharmaceuticals Description and Business Overview
Table 103. CStone Pharmaceuticals Monoclonal Antibody Drug Products, Services and Solutions
Table 104. Revenue (US$ Million) in Monoclonal Antibody Drug Business of CStone Pharmaceuticals (2019-2024)
Table 105. CStone Pharmaceuticals Recent Developments
Table 106. Hillhouse Investment Management Basic Information List
Table 107. Hillhouse Investment Management Description and Business Overview
Table 108. Hillhouse Investment Management Monoclonal Antibody Drug Products, Services and Solutions
Table 109. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Hillhouse Investment Management (2019-2024)
Table 110. Hillhouse Investment Management Recent Developments
Table 111. Alphamab Oncology Basic Information List
Table 112. Alphamab Oncology Description and Business Overview
Table 113. Alphamab Oncology Monoclonal Antibody Drug Products, Services and Solutions
Table 114. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Alphamab Oncology (2019-2024)
Table 115. Alphamab Oncology Recent Developments
Table 116. Novartis Basic Information List
Table 117. Novartis Description and Business Overview
Table 118. Novartis Monoclonal Antibody Drug Products, Services and Solutions
Table 119. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Novartis (2019-2024)
Table 120. Novartis Recent Developments
Table 121. Takeda Pharmaceutical Basic Information List
Table 122. Takeda Pharmaceutical Description and Business Overview
Table 123. Takeda Pharmaceutical Monoclonal Antibody Drug Products, Services and Solutions
Table 124. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Takeda Pharmaceutical (2019-2024)
Table 125. Takeda Pharmaceutical Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Monoclonal Antibody Drug Downstream Customers
Table 129. Monoclonal Antibody Drug Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Monoclonal Antibody Drug Product Picture
Figure 2. Global Monoclonal Antibody Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Monoclonal Antibody Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Monoclonal Antibody Drug Report Years Considered
Figure 5. Global Monoclonal Antibody Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Monoclonal Antibody Drug Revenue in 2023
Figure 7. Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Humanized Monoclonal Antibody Drugs Picture
Figure 9. Fully Human Monoclonal Antibody Drugs Picture
Figure 10. Small Molecule Antibody Drugs Picture
Figure 11. Chimeric Monoclonal Antibody Drugs Picture
Figure 12. Other Picture
Figure 13. Global Monoclonal Antibody Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Monoclonal Antibody Drug Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Cancer Treatment
Figure 16. Product Picture of Autoimmune Disease Treatment
Figure 17. Global Monoclonal Antibody Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Monoclonal Antibody Drug Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Monoclonal Antibody Drug Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Monoclonal Antibody Drug Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Monoclonal Antibody Drug Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Monoclonal Antibody Drug Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Monoclonal Antibody Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Monoclonal Antibody Drug Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Monoclonal Antibody Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Monoclonal Antibody Drug Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Monoclonal Antibody Drug Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Monoclonal Antibody Drug Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Monoclonal Antibody Drug Sales Value (%), (2019-2030)
Figure 30. United States Monoclonal Antibody Drug Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Monoclonal Antibody Drug Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Monoclonal Antibody Drug Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Monoclonal Antibody Drug Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Monoclonal Antibody Drug Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Monoclonal Antibody Drug Sales Value by Application (%), 2023 VS 2030
Figure 36. China Monoclonal Antibody Drug Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Monoclonal Antibody Drug Sales Value by Type (%), 2023 VS 2030
Figure 38. China Monoclonal Antibody Drug Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Monoclonal Antibody Drug Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Monoclonal Antibody Drug Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Monoclonal Antibody Drug Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Monoclonal Antibody Drug Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Monoclonal Antibody Drug Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Monoclonal Antibody Drug Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Monoclonal Antibody Drug Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Monoclonal Antibody Drug Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Monoclonal Antibody Drug Sales Value by Application (%), 2023 VS 2030
Figure 48. India Monoclonal Antibody Drug Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Monoclonal Antibody Drug Sales Value by Type (%), 2023 VS 2030
Figure 50. India Monoclonal Antibody Drug Sales Value by Application (%), 2023 VS 2030
Figure 51. Monoclonal Antibody Drug Industrial Chain
Figure 52. Monoclonal Antibody Drug Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
